Literature DB >> 10509383

Twenty-nine missense mutations linked with familial Alzheimer's disease alter the processing of presenilin 1.

O Murayama1, M Murayama, T Honda, X Sun, N Nihonmatsu, A Takashima.   

Abstract

1. Full-length form of human presenilin 1 (PS1) is processed and an N-terminal fragment (28 KD) and C-terminal fragment (19 KD) are generated. To elucidate the possible role of presenilin mutations in Alzheimer's disease (AD), the authors analyze the effects of AD-linked mutations on PS1 processing in cultured cells. 2. Complementary DNAs encoding genes for human PS1 harboring twenty-nine missense mutations linked with familial Alzheimer's disease (FAD) were introduced into PC12 cells. Human PS1 exogenously expressed in the cells was detected by immunoblotting using a monoclonal antibody that recognized the N-terminal region of human PS1. The amounts of full-length form (48 KD) and N-terminal fragment (28 KD) of PS1 was quantified by densitometrical analysis. 3. The ratio of the N-terminal fragment to total PS1 was reduced by twenty-nine mutations. The specific effects on PS1 processing varied according to mutation. 4. These results suggest that AD-linked missense mutations of PS1 are involved in neurodegeneration via inhibition of PS1 processing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10509383     DOI: 10.1016/s0278-5846(99)00034-2

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  Testing computational prediction of missense mutation phenotypes: functional characterization of 204 mutations of human cystathionine beta synthase.

Authors:  Qiong Wei; Liqun Wang; Qiang Wang; Warren D Kruger; Roland L Dunbrack
Journal:  Proteins       Date:  2010-07

2.  The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers.

Authors:  Bruno A Benitez; Celeste M Karch; Yefei Cai; Sheng Chih Jin; Breanna Cooper; David Carrell; Sarah Bertelsen; Lori Chibnik; Julie A Schneider; David A Bennett; Anne M Fagan; David Holtzman; John C Morris; Alison M Goate; Carlos Cruchaga
Journal:  PLoS Genet       Date:  2013-08-22       Impact factor: 5.917

Review 3.  The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.

Authors:  Jie Shen; Raymond J Kelleher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-29       Impact factor: 11.205

4.  Development of CBAP-BPyne, a probe for γ-secretase and presenilinase.

Authors:  Natalya Gertsik; T Eric Ballard; Christopher W Am Ende; Douglas S Johnson; Yue-Ming Li
Journal:  Medchemcomm       Date:  2014-03       Impact factor: 3.597

5.  Presenilin/γ-secretase regulates neurexin processing at synapses.

Authors:  Carlos A Saura; Emilia Servián-Morilla; Francisco G Scholl
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

Review 6.  Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease.

Authors:  Gary P Morris; Ian A Clark; Bryce Vissel
Journal:  Acta Neuropathol Commun       Date:  2014-09-18       Impact factor: 7.801

7.  Mutational re-modeling of di-aspartyl intramembrane proteases: uncoupling physiologically-relevant activities from those associated with Alzheimer's disease.

Authors:  Anastasia P Grigorenko; Youri K Moliaka; Olga V Plotnikova; Alexander Smirnov; Vera A Nikishina; Andrey Y Goltsov; Fedor Gusev; Tatiana V Andreeva; Omar Nelson; Ilya Bezprozvanny; Evgeny I Rogaev
Journal:  Oncotarget       Date:  2017-05-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.